Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

Keywords

Oncolytic virusMedicineHepatocellular carcinomaImmunotherapyResponse Evaluation Criteria in Solid TumorsOncologyLiver cancerVacciniaCancerInternal medicineImmunologyProgressive diseaseChemotherapyBiology

Affiliated Institutions

Related Publications

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok , Axel Hoos , Steven O’Day +9 more

Abstract Purpose: Immunotherapeutic agents produce antitumor effects by inducing cancer-specific immune responses or by modifying native immune processes. Resulting clinical res...

2009 Clinical Cancer Research 3168 citations

Advances in immunotherapy for hepatocellular carcinoma

Bruno Sangro , Pablo Sarobe , Sandra Hervás‐Stubbs +1 more

Hepatocellular carcinoma (HCC) is a prevalent disease with a progression that is modulated by the immune system. Systemic therapy is used in the advanced stage and until 2017 co...

2021 Nature Reviews Gastroenterology & Hep... 1220 citations

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X. Zhu , Richard S. Finn , Julien Edeline +56 more

Immune checkpoint blockade therapy has shown promising results in patients with advanced hepatocellular carcinoma. We aimed to assess the efficacy and safety of pembrolizumab in...

2018 The Lancet Oncology 2448 citations

Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab

Richard S. Finn , Andrew X. Zhu

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and one of the few malignancies with an increasing incidence in the USA. While the relationship b...

2009 Expert Review of Anticancer Therapy 111 citations

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

Paul Nghiem , Shailender Bhatia , Evan J. Lipson +28 more

BackgroundMerkel-cell carcinoma is an aggressive skin cancer that is linked to exposure to ultraviolet light and the Merkel-cell polyomavirus (MCPyV). Advanced Merkel-cell carci...

2016 New England Journal of Medicine 1214 citations

Publication Info

Year: 2013
Type: article
Volume: 19
Issue: 3
Pages: 329-336
Citations: 746
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

746

OpenAlex

Cite This

APA Style

                            
                                
                                    Jeong Heo, 
                                
                                    Tony Reid, 
                                
                                    Leyo Ruo
                                
                                et al.
                            
                            (2013). 
                            Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. 
                            Nature Medicine
                            , 19
                            (3)
                            , 329-336.
                            https://doi.org/10.1038/nm.3089
                        

Identifiers

DOI: 10.1038/nm.3089